Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1230-1238

  Barankiewicz, Jerzy ^a   Danks, Anne M ^a   Abushanab, Elie ^b   Makings, Lewis ^a   Wiemann, Torsten ^a   Wallis, Roi Ann ^c   Pragnacharyulu, Palle V P ^b   Fox, Anthony ^a   Marangos, Paul J ^a  

^a Cypros Pharmaceutical Corporation   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,2 TRICHLORO 1,2,2 TRIFLUOROETHANE; 5 IODOTUBERCIDIN; 9 (2 HYDROXY 3 NONYL)ADENINE; 9 (2 HYDROXY 9 PHTHALIMIDO 3 NONYL)ADENINE; 9 (9 CHLORO 2 HYDROXY 3 NONYL)ADENINE; 9' CHLORO 9 (2 HYDROXY 3 NONYL)ADENINE; 9' PHTHALIMIDO 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE; DEOXYADENOSINE; DEOXYGLUCOSE; OCTYLAMINE; PENTOSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA CELL; BRAIN HYPOXIA; BRAIN SLICE; CATTLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME INHIBITION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ADENINE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; ASTROCYTOMA; CATTLE; CYTOPROTECTION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HIPPOCAMPUS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0031457278     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. ACHTERBERG, P. W., HARMSEN, E. AND DE JONG, J. W.: Adenosine deaminase inhibition and myocardial purine release during normoxia and ischemia. Cardiovasc. Res. 19: 593-598, 1985.
2. AGARWAL, R. P.: Deoxycoformycin toxicity in mice after long-term treatment. Cancer Chemother. Pharmacol. 5: 83-87, 1980.
3. BAGNARA, A. S., MCDONALD, L. E. AND SLADE, H. M.: Deoxyadenosine toxicity in an adenosine deaminase-inhibited human CCRF-CEM T-lymphoblastoid cell line causes cell swelling. Biochim. Biophys. Acta 1180: 163-172, 1992.
4. BARANKIEWICZ, J., JIMENEZ, R., RONLOV, G., MAGILL, M. AND GRUBER, H. E.: Alteration of purine metabolism by AICA-riboside in human B lymphoblasts. Arch. Biochem. Biophys. 282: 377-385, 1990.
5. BARANKIEWICZ, J., RONLOV, G., JIMENEZ, R. AND GRUBER, H. E.: Selective adenosine release from human B but not T lymphoid cell line. J. Biol. Chem. 265: 15738-15743, 1990.
6. BELLONI, F., L., RUBIO, R. AND BERNE, R. M.: Intracellular adenosine in isolated rat liver cells. Pflueg. Arch. Eur. J. Physiol. 400: 106-108, 1984.
7. BELLONI, F. L., WANG, J. AND HINTZE, T. H.: Adenosine causes bradycardia in pacing-induced cardiac failure. Circulation 85: 1118-1124, 1992.
8. BERNE, R. M.: Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am. J. Physiol 204: 317-322, 1963.
9. BOLLING, S. F., BIES, L. E., BOVE, E. L. AND GALLAGHER, K. P.: Augmenting intracellular adenosine improves myocardial recovery. J. Thorac. Cardiovasc. Surg. 99: 469-474, 1990.
10. BURKE, S. P. AND NADLER, J. V. J.: Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: Effects of adenosine and bactofen. Neurochem. 51: 1541-1551, 1988.
11. CARSON, D. A., KAYE, J. AND SEEGMILLER, J. E.: Lymphocyte toxicity in adenosine deaminase deficiency and purine phosphorylase deficiency: Possible role of nucleoside kinase(s). Proc. Natl. Acad. Sci. USA 74: 5677-5681, 1977.
12. CRONSTEIN, B. N.: Purines and inflammation: Neutrophils posses P1 and P2 purine receptors. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function, ed. by J. W. Phillis, pp. 134-140, CRC Press, Boca Raton/Ann Arbor/Boston/London, 1991.
13. DHASMANA, J. P., DIGEMESS, S. B., GECKLE, J. N., NG, T. C., GLICKSON, J. D. AND BLACKSTONE, E. H.: Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: A study using isolated heart adapted to P-nuclear magnetic resonance. J. Cardiovasc. Pharmacol. 15: 1040-1047, 1983.
14. DORHEIM, T. A., HOFFMAN, A., VAN WYLEN, D. G. L. AND MENTZER, R. M., JR.: Enhanced interstitial fluid adenosine attenuates myocardial stunning. J. Surg. 110: 136-145, 1991.
15. ELY, S. W., MENTZER, R. M., LASLEY, R. D., LEE, B. K. AND BERNE, R. M.: Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J. Thorac Cardiovasc. Surg 90: 549-556, 1985.
16. ELY, S. W. AND BERNE, R. M.: Protective effects of adenosine in myocardial ischemia. Circulation 85: 893-904, 1992.
17. FIRESTEIN, G. S., BULLOUGH, D. A., ERION, M. D., JIMENEZ, R., RAMIREZ-WEINHOUSE, M., BARANKIEWICZ, J., SMITH, C. W., GRUBER, H. E. AND MULLANE, K. M.: Inhibition of neutrophil adhesion by adenosine and adenosine inhibitor. J. Immunol. 154: 326-334, 1995.
18. FOSTER, A., C., MILLER, L. P. AND WIESNER, J. B.: Regulation of endogenous adenosine levels in the CNS: Potential for therapy in stroke, epilepsy and pain. Adv. Exp. Med. Biol. 370: 427-430, 1994.
19. GELFAND, E. W. AND COHEN, A.: Disorder of purine metabolism and immunodeficiency. Adv. Host Defense Mechan. 2: 43-68, 1983.
20. GEIGER, J. D., LEWIS, J. L., MACINTYRE, C. J. AND NAGY, J. I.: Pharmacokinetics of 2′-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat. Neuropharmacology 26: 1383-1387, 1987.
21. GIDDAY, J. M., FITZGIBBONS, J. C., SHAH, A. R., KRAUJALIS, M. J. AND PARK, T. S.: Reduction in cerebral ischemic injury in the newborn rat by potentiation of endogenous adenosine. Pediatr. Res. 38: 306-311, 1995.
22. GREEN, R. D.: Release of Ado by C1300 neuroblastoma cells in tissue culture. J. Supramol. Struct. 13: 175-182, 1980.
23. GRUBER, H. E., HOFFER, M. E., MCALLISTER, D. R., LAIKIND, P. K., LANE, A. T., SCHMID-SCHOENBEIN, G. W. AND ENGLER, R. L.: Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Circulation 80: 1400-1411, 1989.
24. HABAZETTE, H., CONZEN, F. F., VOLLMAR, B., BAIER, H., CHRIST, M., GOETZ, A. E., PETER, K. AND BRENDEL, W.: Dilation of coronary microvessels by adenosine induced hypotension in dogs. Int. J. Microcirc. 11: 51-65, 1992.
25. HUDSPETH, D. A., WILLIAMS, M. W., ZHAO, Z.-Q., SATO, H., NAKANISHI, K., MCGEE, D. S., HAMMON, J. W., JR., VINTEN-JOHANSEN, J. AND VAN WYLEN, D. G. L.: Pentostatin- augmented interstitial adenosine prevents postcardioplegia injury in damaged hearts. Ann. Thorac. Surg. 58: 719-727, 1994.
26. HUDSPETH, D. A., WILLIAMS, M. W., ZHAO, Z.-Q., SATO, H., NAKANISHI, K., MCGEE, D. S., HAMMON, J. W., JR., VINTEN-JOHANSEN, J. AND VAN WYLEN, D. G. L: Pentostatin augments interstitial adenosine and prevents postcardioplegia injury in damaged hearts. Ann. Thorac. Surg. 60: 867, 1995.
27. HUMPHREY, S. M., SEELYE, R. N. AND GRAVIN, J. B.: The influence of adenosine on the non-flow phenomenon in anoxic and ischemic hearts. Pathology 14: 129-133, 1982.
28. KOLLIAS-BAKER, C., SHRYOCK, J. C. AND BELARDINELLI, L.: Myocardial adenosine receptors. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, ed. by L. Belardinelli and A. Pelled, pp. 221-228, Kluwer Academic Publishers, Boston/Dordrecht/London, 1994.
29. LAMBE, C. U. AND NELSON, D. J.: Pharmacokinetics on inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl) adenine in CBA mice. Biochem. Pharmacol. 31: 535-539, 1982.
30. LASLEY, R. D., BUNGER, R. AND MENTZER, R. M.: Receptor-mediated and metabolic effects of adenosine in ischemic and postischemic myocardium. In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, ed. by L. Belardinelli and A. Pelleg, pp. 351-360, Kluwer Academic Publishers, Boston/Dordrecht/London. 1994.
31. LEE, J., HEO, J., OGILBY, J. D., CAVE, V., ISKANDRIAN, B. AND ISKANDRIAN, A. S.: Atrioventricular block during adenosine thallium imaging. Am. Heart J. 123: 1569-1574, 1992.
32. LI, Y. AND KLONER, R. A.: Adenosine deaminase inhibition is not cardioprotective in the rat. Am. Heart J. 126: 1293-1298, 1993.
33. MCCLANAHAN, T. B., IGNASIAK, D. P., MARTIN, B. J., MERTZ, T. E. AND GALLAGHER, K. P.: Inhibition of adenosine deaminase with pentostatin attenuates myocardial stunning in dogs [Abstract]. Circulation. 88: I-187, 1993.
34. 14C] adenine in the rhesus monkey. Drug Metab. Dispos. 8: 5-7, 1980.
35. MENDELSON, W. B., KURUVILLA, A., WATLINGTON, T., GOEHL, K., PAUL, S. M. AND SKOLNICK, P.: Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): Relationship to inhibition of brain adenosine deaminase. Psychopharmacology 79: 126-129, 1983.
36. NIMIT, Y., SKOLNICK, P. AND DALY, J. W.: Adenosine and cyclic AMP in rat cerebral cortical slices: Effects of adenosine uptake inhibitors and adenosine deaminase inhibitors. J. Neurochem. 36: 908-912, 1981.
37. 3H]deoxycoformycin ligand binding. J. Neurochem. 58: 421-429, 1992.
38. PAINE, R. M., WESTON, B. J., CLINK, H. M., KOHN, J., NEVILLE, A. M., MCGHEE, K. G. AND HARRAP, K. R.: Toxicity and immunosuppressive activity of binary combination of 2′-deoxycoformycin and 2′-deoxyadenosine. Cancer Treat. Rep. 65: 259-266, 1981.
39. PENNELL, D. J., UNDERWOOD, S. R. AND ELL, P. J.: Symptomatic bradycardia complicating the use of intravenous dipyridamole for thallim-201 myocardial perfusion imaging. Int. J. Cardiol. 27: 272-274, 1990.
40. PHILLIS, J. W.: Central nervous system effects of adenosine. In Purines in Cellular Signaling, ed. by K. A Jackobson, J. W. Daly and V. Manganiello, pp. 41-47, Springer-Verlag, New York/Berlin/Heidelberg/London/Paris/ Tokyo/Hong Kong, 1990.
41. PHILLIS, J. W.: Adenosine in the control of the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1: 26-54, 1989.
42. PHILLIS, J. W., O'REGAN, M. H. AND WALTER, G. A.: Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine and uric acid release from the hypothermic rat cerebral cortex. J. Cereb. Blood Flow. Metab. 8: 733-741, 1988.
43. RUDOLPHI, K. A., SCHUBERT, P., PARKINSON, F. E. AND FREDHOLM, B. B.: Adenosine and brain ischemia. Cereb. Brain Metab. Rev. 4: 346-369, 1992.
44. SANDHU, G. S., BURRIER, A. C. AND JANERO, D. R.: Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig hearts. Am. J. Physiol. 265: H1249-H1256, 1993.
45. SAWYNOK, J. AND SWEENEY, M. I.: The role of purines in nociception. Neuroscience 32: 557-563, 1989.
46. SCOTTI, V. M. AND VAN WYLEN, D. G. L.: Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J. Cereb. Blood Flow Metab. 13: 201-207, 1993.
47. SILVA, P. H., DILLON, D. AND VAN WYLEN, D. G. L.: Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc. Res. 29: 616-623, 1995.
48. SMOLENSKI, R. T., SUITTERS, A. AND YACOUB, M. H.: Adenine nucleotide catabolism and adenosine formation in isolated human cardiomyocytes. J. Mol. Cell. Cardiol. 24: 91-96, 1992.
49. UNITED STATES PATENT 5,491,146, INVENTOR: ELIE ABUSHANAB, FEBRUARY 13, 1996.
50. VAN BELLE, H.: Nucleoside transport inhibition: A therapeutic approach to cardioprotection via adenosine? Cardiovasc. Res. 27: 68-76, 1993.
51. VAN DEN BERGHE, G., BONTEMPS, F. AND HERS, H. G.: Purine catabolism in isolated rat hepatocytes. Biochem. J. 188: 913-919, 1980.
52. XIA, Y., KHATCHIKIAN, G. AND ZWEIER, J. L.: Adenosine deaminase inhibition prevents free radical-mediated injury in the postischemic heart. J. Biol. Chem. 271: 10096-10102, 1996.
53. ZETTERSTROM, T., VERNET, L., UNGERSTEDT, U., TOSSMAN, U., JONZON, B. AND FREDHOLM, B. B.: Purine levels in the intact rat brain: Studies with an implanted perfused hollow fiber. Neurosci. Lett. 29: 111-115, 1982.
54. ZHU, Q., YANG, X., CLAYDON, M. A., HICKS, G. L., JR. AND WANG T.: Adenosine deaminase inhibitor in cardioplegia enhanced function preservation of the hypothermically stored rat heart. Transplantation 57: 35-40, 1994.
55. ZOREF-SHANI, E., KESSLER-ICEKSOEN, G. AND SPERLING, O.: Pathways of adenine nucleotide catabolism in primary rat cardiomyocyte cultures. J. Mol. Cell. Cardiol. 20: 23-33, 1988.
56. ZUGHAIB, M. E., ABD-ELFATTAH, A. S., JEROUDI, M. O., SUN, J. Z. SEKILI, S. AND TANG, X. L. AND BOLLI R.: Augmentation of endogenous adenosine attenuates myocardial stunning independently of coronary flow or hemodynamic effects. Circulation 88: 2359-2369, 1993.